Mysona, David Pierce http://orcid.org/0000-0003-4203-1123
Ghamande, Sharad
She, Jin-Xiong
Tran, Lynn
Tran, Paul
Rungruang, Bunja J.
Chan, John K.
Bae-Jump, Victoria
Gehrig, Paola A.
Article History
Received: 22 June 2020
Accepted: 15 October 2020
First Online: 5 November 2020
Disclosure
: David P. Mysona, Sharad Ghamande, Jin-Xiong She, Lynn Tran, Paul Tran, Bunja J. Rungruang, John K. Chan, Victoria Bae-Jump, and Paola A. Gehrig have no conflicts of interest in relation to the submitted work. Outside of the submitted work, Dr Ghamande has received compensation from GlaxoSmithKline for consulting and from Merck as part of their speakers’ bureau. Dr. Chan has received compensation from Acerta, Aravive, Biodesix, Clovis, Janssen/J&J, Oxigen/Mateon, Roche/Genentech, Tesaro, Astra Zeneca, and Eisai.